Asston Pharmaceuticals Ltd shares jump 3.5% as SEBI disclosure received for Prakruti R Pali takeover
Why did Asston Pharmaceuticals Ltd shares jump today?
Asston Pharmaceuticals Ltd shares saw a notable jump today, rising by 3.5%. The current share price stands at ₹113.8 as of 02:48 PM on Monday. This upward movement in the stock price is directly linked to a significant regulatory disclosure made to the stock exchanges.
The news is about an acquisition of shares by an investor named Prakruti R Pali. As per the disclosure filed under SEBI regulations, Prakruti R Pali, who is not part of the company's promoter group, has acquired an additional 1,64,000 shares. This acquisition increased their total holding in the company from 4,54,000 shares to 6,18,000 shares, raising their stake from 5.33% to 7.26% of the company's total voting capital. This kind of substantial acquisition by a known investor is often viewed positively by the market as a vote of confidence in the company's prospects.
Such a significant increase in holding by an individual investor under the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations typically signals strong belief in the company's future growth. This positive sentiment has likely attracted more buying interest, contributing to the sharp 3.5% rise in Asston Pharmaceuticals' share price during today's trading session.
What does Asston Pharmaceuticals Ltd do?
Asston Pharmaceuticals Limited is a publicly listed company whose shares are traded on the Bombay Stock Exchange SME Platform. It is the target company in a disclosure regarding the acquisition of its shares under SEBI regulations. The company has a total share capital, with a substantial portion representing voting rights.
The company operates within the pharmaceuticals sector. An individual named Prakruti R Pali is noted as an acquirer, holding shares representing 5.33% of the company's total diluted voting capital prior to the acquisition under consideration.
Asston Pharmaceuticals Ltd Financials
In CroresAsston Pharmaceuticals Ltd's revenue grew from ₹9.07 crore in March 2025 to ₹10.05 crore in March 2026, representing an increase of approximately 10.8%. However, this top-line growth did not translate to the bottom line, as the company's profit significantly declined from ₹1.95 crore to ₹0.48 crore over the same period, indicating a substantial contraction in profitability despite higher sales.
Asston Pharmaceuticals Ltd Shareholding Pattern
Promoter holding stands at 50.66% of the total share capital. Foreign Institutional Investors (FIIs) hold 1.91% stake in the company, while Domestic Institutional Investors (DIIs) hold 0.0%. Public shareholders hold the remaining 47.41% stake in Asston Pharmaceuticals Ltd.
Asston Pharmaceuticals Ltd FAQs
Q: Why did Asston shares jump 3.5% today?
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakruti R Pali. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Asston Pharmaceuticals Ltd?
As per the latest data, promoters hold 50.66% stake in Asston Pharmaceuticals Ltd, while FII holding stands at 1.91%. Domestic institutional investors hold 0.0%, and public shareholders account for 47.41% of the equity.
Q: What is the current stock price of Asston Pharmaceuticals Ltd?
Asston Pharmaceuticals Ltd shares are currently trading at ₹113.8, recording a gain of 3.5% from the previous close.
Q: What is the market capitalization of Asston Pharmaceuticals Ltd?
The company currently has a market capitalization of ₹96.87 crore, reflecting its valuation in the Indian equity market.